Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2‐B3) and thymic carcinoma previously treated with chemotherapy
Journal article published in 2021 by
Matteo Perrino,
Tommaso De Pas,
Silvia Bozzarelli,
Laura Giordano,
Fabio De Vincenzo,
Fabio Conforti 
,
Nunzio Digiacomo,
Nadia Cordua,
Federica D'Antonio,
Federica Borea,
Armando Santoro ,
Paolo Andrea Zucali
,
Nunzio Digiacomo,
Nadia Cordua,
Federica D'Antonio,
Federica Borea,
Armando Santoro ,
Paolo Andrea Zucali
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 